Losartan 50mg Tablet, 30 count each blister card.
Published April 17, 2019 · Recall initiated: March 14, 2019
Summary
FDA records drug Class II recall D-1081-2019, published April 17, 2019 and initiated March 14, 2019. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 33 blister cards of 30 = 990 tablets; Lot: 70518-0588-01, Lot #: J0328416-101518, Exp. Date: 10/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RemedyRepack Inc.
- Distributor
- Product was distributed to one sole customer, Miami, FL.
- Lot
- 70518-0588-01, Lot #: J0328416-101518, Exp. Date: 10/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc.,April 30, 2025
- FDACarvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark,February 12, 2025
- FDADuloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottlesJanuary 1, 2025
- FDAPotassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG:July 24, 2024
- FDASODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996April 17, 2019
- FDAMicro Knife 5.0mm 30®, Part Number 0001522 The Beaver® Micro Knife 5.0mm 30® is a sharp pointed tip intendedApril 10, 2019
Questions about this recall
Was Losartan 50mg Tablet, 30 count each blister card. recalled?
Yes. FDA published recall D-1081-2019 on April 17, 2019. Reported hazard: CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).
What should I do if I have this product?
Voluntary: Firm initiated · Letter